Sign In
16 Sep 2009 16:20
16 September 2009
Consort Medical plc
Annual General Meeting Resolutions
Consort Medical plc (LSE: CSRT), today held its Annual General Meeting for the year ended 30 April 2009. All resolutions were duly approved.
For further information, please contact:
|
Consort Medical plc |
|
|
Jonathan Glenn, Chief Executive |
Tel: +44 (0) 1442 867920 |
|
Toby Woolrych, Group Finance Director |
Tel: +44 (0) 1442 867920 |
|
Brunswick |
|
|
Jon Coles/Justine McIlroy |
Tel: +44 (0) 20 7404 5959 |
Consort Medical plc is a leader in medical devices for inhaled drug delivery and anaesthesia. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.
Consort Medical develops and manufactures metered dose inhaler valves, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits and laryngeal tubes. The Group has facilities in King's Lynn and Hemel Hempstead in the UK, Indianapolis, Indiana and Kent, Ohio in the US, and Mumbai, India. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).
Follow the stocks
